SAFEGUARD SCIENTIFICS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SAFEGUARD SCIENTIFICS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2009 | $34.84M | Mar 2, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $110.60M | Mar 2, 2012 |
| FY2011 | Dec 31, 2010 | $26.61M | Mar 2, 2012 |
| FY2011 | Dec 31, 2009 | $67.61M | Mar 2, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($2.00M) | Mar 26, 2024 |
| FY2023 | Sep 30, 2023 | ($1.31M) | Mar 26, 2024 |
| FY2023 | Jun 30, 2023 | ($1.19M) | Mar 26, 2024 |
| FY2023 | Mar 31, 2023 | ($1.19M) | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | ($1.04M) | Mar 26, 2024 |
| FY2023 | Sep 30, 2022 | ($1.36M) | Mar 26, 2024 |
| FY2023 | Jun 30, 2022 | ($1.15M) | Mar 26, 2024 |
| FY2023 | Mar 31, 2022 | ($1.23M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($1.14M) | Mar 10, 2023 |
| FY2022 | Sep 30, 2021 | ($1.56M) | Mar 10, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $21.17M | Mar 2, 2012 |
| FY2011 | Dec 31, 2010 | $20.85M | Mar 2, 2012 |
| FY2011 | Dec 31, 2009 | $37.21M | Mar 2, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($3.31M) | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | ($3.26M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($8.15M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($8.14M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($19.97M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($26.04M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($20.81M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($18.66M) | Mar 7, 2018 |
| FY2017 | Dec 31, 2015 | ($17.75M) | Mar 7, 2018 |
| FY2016 | Dec 31, 2014 | ($20.19M) | Mar 3, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $22.84M | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | $37.69M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $54.03M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $69.04M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $107.58M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $145.74M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $176.46M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $231.83M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $256.84M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | $318.45M | Mar 4, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.86M | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | $3.12M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $3.46M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $6.16M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $5.84M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $78.76M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $94.67M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $62.05M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $61.34M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | $60.63M | Mar 4, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($733.73M) | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | ($723.90M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($709.64M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($736.64M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($697.22M) | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | ($731.11M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($715.48M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($626.90M) | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | ($604.27M) | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | ($544.75M) | Mar 4, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $9.50M | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | $13.33M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $24.74M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $15.60M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $25.03M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $7.70M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $20.75M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $22.06M | Mar 7, 2018 |
| FY2016 | Dec 31, 2015 | $32.84M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | $111.90M | Mar 4, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $68.60M | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 10, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 10, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Mar 26, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 10, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 10, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 21.57M | Mar 11, 2022 |
| FY2021 | Dec 31, 2020 | 21.57M | Mar 11, 2022 |
| FY2013 | Dec 31, 2013 | 21.55M | Aug 28, 2014 |
| FY2013 | Dec 31, 2012 | 20.97M | Aug 28, 2014 |
| FY2012 | Dec 31, 2011 | 20.75M | Mar 11, 2013 |
| FY2011 | Dec 31, 2010 | 20.63M | Mar 2, 2012 |